Copyright investors
On Monday, Enova International (ENVA) got an upgrade for its IBD SmartSelect Composite Rating from 91 to 96. The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs. Enova International is now out of buy range after clearing the 119.06 buy point in a consolidation. The stock earns a 91 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 91% of all stocks. Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks. The company reported a 37% rise in earnings for Q3. Sales growth fell to 16%, down from 22% in the previous quarter. Enova International earns the No. 3 rank among its peers in the Finance-Consumer Loans industry group. SoFi Technologies (SOFI) is the No. 1-ranked stock within the group. This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article. YOU MAY ALSO LIKE
